Cargando…

Pharmacogenetics of Osteoporosis: A Pathway Analysis of the Genetic Influence on the Effects of Antiresorptive Drugs

Osteoporosis is a skeletal disorder defined by a decreased bone mineral density (BMD) and an increased susceptibility to fractures. Bisphosphonates and selective oestrogen receptor modulators (SERM) are among the most widely used drugs. They inhibit bone resorption by targeting the mevalonate and oe...

Descripción completa

Detalles Bibliográficos
Autores principales:	del Real, Álvaro, Valero, Carmen, Olmos, José M., Hernández, Jose L., Riancho, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032991/ https://www.ncbi.nlm.nih.gov/pubmed/35456610 http://dx.doi.org/10.3390/pharmaceutics14040776

Ejemplares similares

Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
por: del Real, Alvaro, et al.
Publicado: (2022)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Composition and Properties of Saliva in Patients with Osteoporosis Taking Antiresorptive Drugs
por: Sobczak-Jaskow, Hanna, et al.
Publicado: (2023)

Influence of hyperbaric oxygen therapy on bone metabolism in patients with neoplasm
por: Salmón-González, Zaida, et al.
Publicado: (2021)

Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
por: Zhang, Chenggui, et al.
Publicado: (2021)

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
por: Leder, Benjamin Z
Publicado: (2018)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis
por: Reginster, J. Y., et al.
Publicado: (2014)

Epigenetics of Osteoporosis: Critical Analysis of Epigenetic Epidemiology Studies
por: Riancho, José A.
Publicado: (2015)

Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2022)

Hyperbaric Oxygen Therapy Does Not Have a Negative Impact on Bone Signaling Pathways in Humans
por: Salmón-González, Zaida, et al.
Publicado: (2021)

Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis
por: Lou, Shenghan, et al.
Publicado: (2017)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Two Cases of External Auditory Canal Osteonecrosis in Patients on Antiresorptive Therapy for Osteoporosis
por: Kumar, Shejil, et al.
Publicado: (2023)

P02 When should we stop the antiresorptive medications in patients with osteoporosis?
por: Mohareb, Marwa, et al.
Publicado: (2023)

In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis
por: Ko, Chun-Hay, et al.
Publicado: (2012)

Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients
por: Morishita, Kota, et al.
Publicado: (2022)

The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
por: Schwarz, Peter, et al.
Publicado: (2011)

Influence of meteorological factors on the severity of COVID-19 in Spain: Observational ecological study
por: Valero, Carmen, et al.
Publicado: (2023)

Green tea extract synergistically enhances the effectiveness of an antiresorptive drug on management of osteoporosis induced by ovariectomy in a rat model
por: Siu, Wing Sum, et al.
Publicado: (2021)

Vitamin D Receptor Gene Polymorphisms Affect Osteoporosis-Related Traits and Response to Antiresorptive Therapy
por: Mondockova, Vladimira, et al.
Publicado: (2023)

Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes
por: Vilaca, Tatiane, et al.
Publicado: (2023)

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)

Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021
por: Wadhwa, Harsh, et al.
Publicado: (2023)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo
por: Ottewell, PD, et al.
Publicado: (2006)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
por: Chhabra, Harvinder, et al.
Publicado: (2015)

Effects of Systemic or Local Administration of Mesenchymal Stem Cells from Patients with Osteoporosis or Osteoarthritis on Femoral Fracture Healing in a Mouse Model
por: Laguna, Esther, et al.
Publicado: (2022)

Influence of weather factors on the incidence of COVID-19 in Spain
por: Valero, Carmen, et al.
Publicado: (2022)

Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women
por: Riancho, José A, et al.
Publicado: (2008)

Dental care for patients taking antiresorptive drugs: a literature review
por: Song, Minju
Publicado: (2019)

Antiresorptive Drugs and the Risk of Femoral Shaft Fracture in Men and Women With Osteoporosis: A Cohort Study Using the National Database of Health Insurance Claims of Japan
por: Imai, Takumi, et al.
Publicado: (2023)

Influence of antiresorptive/antiangiogenic therapy on the extension of experimentally induced peri-implantitis lesions
por: Schwarz, Frank, et al.
Publicado: (2023)

Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis
por: Liu, Chang, et al.
Publicado: (2022)

Pharmacogenetics of lipid diseases
por: Ordovas, Jose M
Publicado: (2004)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
por: Woolley, Julian, et al.
Publicado: (2021)

Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes
por: Omori, Keisuke, et al.
Publicado: (2022)

The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
por: Kincse, Gyöngyvér, et al.
Publicado: (2012)

Romosozumab and antiresorptive treatment: the importance of treatment sequence
por: Cosman, Felicia, et al.
Publicado: (2022)

Influencia de los factores meteorológicos en la gravedad de la COVID-19 en España: estudio observacional ecológico
por: Valero, Carmen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nl26ts1ecmuft56sj7n7sbkf1n